Pasithea Therapeutics Ownership 2024 | Who Owns Pasithea Therapeutics Now?
Institutional Ownership
0.99%
Institutional Holders
8.00
Pasithea Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
JPMORGAN CHASE & CO | - | - | - | -3,000 | -100.00% | - | Mar 31, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -127 | -100.00% | - | Mar 31, 2024 |
NORTHERN TRUST CORP | - | - | - | -47,074 | -100.00% | - | Mar 31, 2024 |
ROYAL BANK OF CANADA | - | - | - | -5,000 | -100.00% | - | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -32,500 | -100.00% | - | Mar 31, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -125,123 | -100.00% | - | Mar 31, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -12,396 | -100.00% | - | Mar 31, 2024 |
JANE STREET GROUP, LLC | - | - | - | -23,588 | -100.00% | - | Mar 31, 2024 |
Pasithea Therapeutics's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
JPMORGAN CHASE & CO | - | - | - | -3,000 | -100.00% | - | Mar 31, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -127 | -100.00% | - | Mar 31, 2024 |
NORTHERN TRUST CORP | - | - | - | -47,074 | -100.00% | - | Mar 31, 2024 |
ROYAL BANK OF CANADA | - | - | - | -5,000 | -100.00% | - | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -32,500 | -100.00% | - | Mar 31, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -125,123 | -100.00% | - | Mar 31, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -12,396 | -100.00% | - | Mar 31, 2024 |
JANE STREET GROUP, LLC | - | - | - | -23,588 | -100.00% | - | Mar 31, 2024 |
The largest Pasithea Therapeutics shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Pasithea Therapeutics (KTTA), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -127 | -100.00% | - | Mar 31, 2024 |
JPMORGAN CHASE & CO | - | - | - | -3,000 | -100.00% | - | Mar 31, 2024 |
ROYAL BANK OF CANADA | - | - | - | -5,000 | -100.00% | - | Mar 31, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -12,396 | -100.00% | - | Mar 31, 2024 |
JANE STREET GROUP, LLC | - | - | - | -23,588 | -100.00% | - | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -32,500 | -100.00% | - | Mar 31, 2024 |
NORTHERN TRUST CORP | - | - | - | -47,074 | -100.00% | - | Mar 31, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -125,123 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Pasithea Therapeutics's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.13K stocks of KTTA, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -125,123 | -100.00% | - | Mar 31, 2024 |
NORTHERN TRUST CORP | - | - | - | -47,074 | -100.00% | - | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -32,500 | -100.00% | - | Mar 31, 2024 |
JANE STREET GROUP, LLC | - | - | - | -23,588 | -100.00% | - | Mar 31, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -12,396 | -100.00% | - | Mar 31, 2024 |
ROYAL BANK OF CANADA | - | - | - | -5,000 | -100.00% | - | Mar 31, 2024 |
JPMORGAN CHASE & CO | - | - | - | -3,000 | -100.00% | - | Mar 31, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -127 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Pasithea Therapeutics's biggest institutional seller is GEODE CAPITAL MANAGEMENT, LLC. The company sold -0.13M shares of KTTA, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -125,123 | -100.00% | - | Mar 31, 2024 |
NORTHERN TRUST CORP | - | - | - | -47,074 | -100.00% | - | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -32,500 | -100.00% | - | Mar 31, 2024 |
JANE STREET GROUP, LLC | - | - | - | -23,588 | -100.00% | - | Mar 31, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -12,396 | -100.00% | - | Mar 31, 2024 |
ROYAL BANK OF CANADA | - | - | - | -5,000 | -100.00% | - | Mar 31, 2024 |
JPMORGAN CHASE & CO | - | - | - | -3,000 | -100.00% | - | Mar 31, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -127 | -100.00% | - | Mar 31, 2024 |
Pasithea Therapeutics's largest sold out institutional shareholder by shares sold is GEODE CAPITAL MANAGEMENT, LLC, sold -0.13M shares, valued at -, as of undefined.
Pasithea Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.00% | 117,393 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 138,145 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 967 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 8,995 | - | - | Mar 31, 2024 |
Pasithea Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 117.39K shares, compromising 0.00% of its total assets.
Pasithea Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Dec, 23 | 8 | -33.33% |
30 Sep, 23 | 12 | - |
30 Jun, 23 | 12 | - |
31 Mar, 23 | 12 | 9.09% |
31 Dec, 22 | 11 | 37.50% |
30 Sep, 22 | 8 | - |
30 Jun, 22 | 8 | 14.29% |
31 Mar, 22 | 7 | 16.67% |
31 Dec, 21 | 6 | 50.00% |
30 Sep, 21 | 4 | - |
As of 31 Dec 23, 8 institutions are holding Pasithea Therapeutics's shares, representing a decrease of -33.33% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Dec, 23 | 248,808 | -2.59% |
30 Sep, 23 | 255,417 | -32.44% |
30 Jun, 23 | 378,085 | -1.83% |
31 Mar, 23 | 385,124 | -39.00% |
31 Dec, 22 | 631,393 | -22.91% |
30 Sep, 22 | 818,998 | 27.19% |
30 Jun, 22 | 643,939 | -14.98% |
31 Mar, 22 | 757,381 | 23.29% |
31 Dec, 21 | 614,318 | 47.83% |
30 Sep, 21 | 415,564 | - |
Pasithea Therapeutics (KTTA) has 248.81K shares outstanding as of 31 Dec 23, down -2.59% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Dec, 23 | 0.99% | 103.48% |
30 Sep, 23 | 0.98% | 46.49% |
30 Jun, 23 | 1.45% | 66.46% |
31 Mar, 23 | 1.48% | 23.62% |
31 Dec, 22 | 2.50% | 26.27% |
30 Sep, 22 | 3.08% | 40.89% |
30 Jun, 22 | 2.75% | 25.35% |
31 Mar, 22 | 3.29% | 46.18% |
31 Dec, 21 | 2.67% | 81.85% |
30 Sep, 21 | 1.81% | - |
As of 31 Dec 23, Pasithea Therapeutics is held by 0.99% institutional shareholders, representing a 103.48% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Dec, 23 | 3 | -57.14% |
30 Sep, 23 | 7 | 40.00% |
30 Jun, 23 | 5 | 25.00% |
31 Mar, 23 | 4 | -50.00% |
31 Dec, 22 | 8 | 100.00% |
30 Sep, 22 | 4 | -33.33% |
30 Jun, 22 | 6 | 20.00% |
31 Mar, 22 | 5 | -16.67% |
31 Dec, 21 | 6 | 50.00% |
30 Sep, 21 | 4 | - |
3 institutional shareholders have increased their position in KTTA stock as of 31 Dec 23 compared to 7 in the previous quarter (a -57.14% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Dec, 23 | 2 | -33.33% |
30 Sep, 23 | 3 | - |
30 Jun, 23 | 3 | - |
31 Mar, 23 | 3 | 50.00% |
31 Dec, 22 | 2 | 100.00% |
30 Sep, 22 | 1 | - |
30 Jun, 22 | 1 | - |
31 Mar, 22 | - | - |
31 Dec, 21 | - | - |
30 Sep, 21 | - | - |
2 institutional shareholders have reduced their position in KTTA stock as of 31 Dec 23 compared to 3 in the previous quarter (a -33.33% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec, 23 | 8 | -33.33% | 248,808 | -2.59% | 0.99% | 103.48% | 3 | -57.14% | 2 | -33.33% |
30 Sep, 23 | 12 | - | 255,417 | -32.44% | 0.98% | 46.49% | 7 | 40.00% | 3 | - |
30 Jun, 23 | 12 | - | 378,085 | -1.83% | 1.45% | 66.46% | 5 | 25.00% | 3 | - |
31 Mar, 23 | 12 | 9.09% | 385,124 | -39.00% | 1.48% | 23.62% | 4 | -50.00% | 3 | 50.00% |
31 Dec, 22 | 11 | 37.50% | 631,393 | -22.91% | 2.50% | 26.27% | 8 | 100.00% | 2 | 100.00% |
30 Sep, 22 | 8 | - | 818,998 | 27.19% | 3.08% | 40.89% | 4 | -33.33% | 1 | - |
30 Jun, 22 | 8 | 14.29% | 643,939 | -14.98% | 2.75% | 25.35% | 6 | 20.00% | 1 | - |
31 Mar, 22 | 7 | 16.67% | 757,381 | 23.29% | 3.29% | 46.18% | 5 | -16.67% | - | - |
31 Dec, 21 | 6 | 50.00% | 614,318 | 47.83% | 2.67% | 81.85% | 6 | 50.00% | - | - |
30 Sep, 21 | 4 | - | 415,564 | - | 1.81% | - | 4 | - | - | - |
Pasithea Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
All Insider Owners Trades
Pasithea Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 2 | - | - |
Q1 2024 | 18 | - | - |
Q2 2023 | 1 | 1 | 100.00% |
Q4 2022 | 16 | 2 | 800.00% |
Q3 2022 | 13 | - | - |
Q2 2022 | 8 | - | - |
Q4 2021 | 2 | - | - |
Q3 2021 | 2 | 3 | 66.67% |
2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Pasithea Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | - | - | - |
Q1 2024 | - | - | - |
Q2 2023 | 1 | - | - |
Q4 2022 | 1 | - | - |
Q3 2022 | 13 | - | - |
Q2 2022 | - | - | - |
Q4 2021 | - | - | - |
Q3 2021 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Pasithea Therapeutics's stocks.
Pasithea Therapeutics Peer Ownership
Ticker | Company |
---|---|
BWV | Onconetix, Inc. |
ABVC | ABVC BioPharma, Inc. |
KPRX | Kiora Pharmaceuticals, Inc. |
PXMD | PaxMedica, Inc. Common Stock |
REVB | Revelation Biosciences, Inc. |
QNRX | Quoin Pharmaceuticals, Ltd. |
HILS | Tharimmune, Inc. |
KRON | Kronos Bio, Inc. |
VRAX | Virax Biolabs Group Limited |
MNOV | MediciNova, Inc. |
RNXT | RenovoRx, Inc. |
INDP | Indaptus Therapeutics, Inc. |
KZR | Kezar Life Sciences, Inc. |
FBRX | Forte Biosciences, Inc. |
ELYM | Eliem Therapeutics, Inc. |
KTTA Ownership FAQ
Who Owns Pasithea Therapeutics?
Pasithea Therapeutics is owned by institutional shareholders (0.99%), insiders (0.00%), and public (99.01%). The largest institutional shareholder of Pasithea Therapeutics is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of Pasithea Therapeutics?
Pasithea Therapeutics's major institutional shareholders are JPMORGAN CHASE & CO, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, ROYAL BANK OF CANADA, and RENAISSANCE TECHNOLOGIES LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Pasithea Therapeutics shareholders are there?
As of Dec 2023, there are 8 institutional shareholders of Pasithea Therapeutics.
What percentage of Pasithea Therapeutics is owned by JPMORGAN CHASE & CO?
JPMORGAN CHASE & CO owns 0 shares of Pasithea Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).
What percentage of Pasithea Therapeutics is owned by WELLS FARGO & COMPANY/MN?
As of Mar 2024, WELLS FARGO & COMPANY/MN holds 0 shares of Pasithea Therapeutics (KTTA), compromising 0% of the company, valued at $0.
What percentage of Pasithea Therapeutics is owned by NORTHERN TRUST CORP?
NORTHERN TRUST CORP is the third largest holder of Pasithea Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).